Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders

@article{Fang2017QuantitativeAS,
  title={Quantitative and Systems Pharmacology 3. Network-Based Identification of New Targets for Natural Products Enables Potential Uses in Aging-Associated Disorders},
  author={Jiansong Fang and Li Gao and Huili Ma and Qihui Wu and Tian Wu and Jun Wu and Qi Wang and Feixiong Cheng},
  journal={Frontiers in Pharmacology},
  year={2017},
  volume={8}
}
Aging that refers the accumulation of genetic and physiology changes in cells and tissues over a lifetime has been shown a high risk of developing various complex diseases, such as neurodegenerative disease, cardiovascular disease and cancer. Over the past several decades, natural products have been demonstrated as anti-aging interveners via extending lifespan and preventing aging-associated disorders. In this study, we developed an integrated systems pharmacology infrastructure to uncover new… 
View on PubMed
frontiersin.org
33 Citations
Background Citations
3
Results Citations
1

Figures and Tables from this paper

33 Citations

Quantitative and systems pharmacology 4. Network-based analysis of drug pleiotropy on coronary artery disease.

An Insight Into the Molecular Mechanism of Berberine Towards Multiple Cancer Types Through Systems Pharmacology

This study systematically provides a powerful strategy to identify potential anti-cancer effects of berberine with novel mechanisms from a systems pharmacology perspective.

In silico identification of natural products from Traditional Chinese Medicine for cancer immunotherapy

A quantitative and systems pharmacology-based framework to identify TCM-derived natural products for cancer immunotherapy and showcased that three typical natural products in Huangqin potentially overcome resistance of known oncology agents by regulating tumor immunosuppressive microenvironments.

Aging and drug discovery

A consensus is emerging both in industry and academia, that molecules able to intervene in the aging process may contain the potential to transform both societies and healthcare.

Aging and drug

An overview of the presented talks and discussion points of the 5th Annual Aging and Drug Discovery Forum 2018 in Basel, Switzerland, which discussed the mechanistic cause of aging, how longevity signatures may be highly conserved, and emerging biomarkers of aging.

Structural similarity-based prediction of the potential active ingredients and mechanism of action of traditional Chinese medicine formulations used to anti-aging

Antioxidant Effects of Caffeic Acid Lead to Protection of Drosophila Intestinal Stem Cell Aging

Oral administration with CA significantly delayed age-associated Drosophila gut dysplasia caused by the dysregulation of intestinal stem cells (ISCs) upon aging and supplementation significantly ameliorated the gut hyperplasia defect and reduced environmentally induced mortality.

Aryl hydrocarbon receptor: From pathogenesis to therapeutic targets in aging-related tissue fibrosis

Application value of quantitative system pharmacology in drug discovery for traditional Chinese medicine

The early intervention and full participation of QSP in the development of new drugs discovery can form a model-led drug development model to improve the efficiency of drug discovery and scientific appraise, reduce the cost of research and development, and shorten the time to market for new drugs.

A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling.

References

SHOWING 1-10 OF 83 REFERENCES

Current Perspective in the Discovery of Anti-aging Agents from Natural Products

These compounds or extracts and their mechanisms in increasing longevity of Caenorhabditis elegans or other species, and the prospect in developing anti-aging medicine from natural products are summarized.

Quantitative and Systems Pharmacology. 1. In Silico Prediction of Drug-Target Interactions of Natural Products Enables New Targeted Cancer Therapy.

This study reconstructed a global drug-target network with 7,314 interactions connecting 751 targets and 2,388 natural products and built predictive network models via a balanced substructure-drug- target network-based inference approach and showed that the significantly predicted anticancer indications of multiple natural products with new mechanism-of-action were validated.

Molecular mechanisms for anti-aging by natural dietary compounds.

This review summarizes the current understanding on signaling pathways of aging and knowledge and underlying mechanism of natural dietary compounds that provide potential application on anti-aging and improve heath in human.

Computational prediction of microRNA networks incorporating environmental toxicity and disease etiology

A computational systems toxicology framework to predict new associations among EFs, miRNAs and diseases by integrating EF structure similarity and disease phenotypic similarity is developed and successfully inferred novel EF-miRNAs networks in two case studies for breast cancer and cigarette smoke.

In silico polypharmacology of natural products

The promise of cancer immunotherapies and combination therapies that target tumor ecosystems (e.g. clones or 'selfish' sub-clones) via exploiting the immunological and inflammatory 'side' effects of natural products in the cancer post-genomics era is highlighted.

In search for geroprotectors: in silico screening and in vitro validation of signalome-level mimetics of young healthy state

PD-98059, a highly selective MEK1 inhibitor, showed both life-prolonging and rejuvenating effects and natural compounds like N-acetyl-L-cysteine, Myricetin and Epigallocatechin gallate improved several senescence-associated properties and were further investigated with pathway analysis.

Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?

Examination of recent evidence suggests that inhibition of protein tyrosine phosphatase 1B (PTP1B) may represent a promising strategy to combat a variety of AD-related detrimental processes.

Aging and drug discovery

A consensus is emerging both in industry and academia, that molecules able to intervene in the aging process may contain the potential to transform both societies and healthcare.

The Hallmarks of Aging

Network-based identification of microRNAs as potential pharmacogenomic biomarkers for anticancer drugs

The SMiR-NBI model would provide a powerful tool to identify potential pharmacogenomic biomarkers characterized by miRNAs in the emerging field of precision cancer medicine, which is available at http://lmmd.ecust.edu.cn/database/smir-nbi/.
...